Cytokinetics Inc. (CYTK) on GreekSoup https://greeksoup.ai/stocks/us/cytk/ Every dated entry in the public record on Cytokinetics Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 09 Oct 2026 00:00:00 +0000 Cytokinetics Inc.: Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at $61.38 on 6 October 2026, $214,830https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-10-06:b5fd679d9cTue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Blum Robert I (President & CEO) sold 7,500 shares at $65.46 on 28 September 2026, $490,950https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-09-28:25093104bdMon, 28 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at $68.29 on 22 September 2026, $239,015https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-09-22:5704f0d03cTue, 22 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Form 144, Robert I. Blum plans to sell 97,926 shares worth $7.1 million around 15 September 2026https://greeksoup.ai/stocks/us/cytk/planned-sales/us:CYTK:planned-sale:2026-09-15:89d94e5653Tue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Landry Robert E (Director) sold 1,000 shares at $72.13 on 15 September 2026, $72,130https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-09-15:3fc11706e6Tue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Blum Robert I (President & CEO) sold 97,926 shares at $69.33 on 15 September 2026, $6.8 millionhttps://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-09-15:a70d532285Tue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Blum Robert I (President & CEO) sold 7,500 shares at $73.44 on 14 September 2026, $550,800https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-09-15:3ca355877cTue, 15 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: short interest 17,481,383 shares at the 15 September 2026 settlement, 10.55 days to coverhttps://greeksoup.ai/stocks/us/cytk/short-interest/us:CYTK:short-interest:2026-09-15:224fc03f36Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Form 144, ROBERT LANDRY plans to sell 2,000 shares worth $147,240 around 11 September 2026https://greeksoup.ai/stocks/us/cytk/planned-sales/us:CYTK:planned-sale:2026-09-11:b22fd57070Fri, 11 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Landry Robert E (Director) sold 1,000 shares at $74.66 on 11 September 2026, $74,660https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-09-11:f4338bbfebFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at $75.46 on 8 September 2026, $264,110https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-09-08:87f689bb58Tue, 08 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Form 144, B LYNNE PARSHALL plans to sell 5,000 shares worth $354,550 around 1 September 2026https://greeksoup.ai/stocks/us/cytk/planned-sales/us:CYTK:planned-sale:2026-09-01:ee536a7d5cTue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Parshall B Lynne (Director) sold 5,000 shares at $71.48 on 1 September 2026, $357,400https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-09-01:0301b66d56Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Callos Andrew (EVP, Chief Commercial Officer) sold 10,000 shares at $70.24 on 31 August 2026, $702,400https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-08-31:62ca1b8c55Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Blum Robert I (President & CEO) sold 7,500 shares at $70.24 on 31 August 2026, $526,800https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-08-31:6880385d5aMon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: short interest 17,442,378 shares at the 31 August 2026 settlement, 9.73 days to coverhttps://greeksoup.ai/stocks/us/cytk/short-interest/us:CYTK:short-interest:2026-08-31:d2308e2d23Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Cytokinetics Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/cytk/filings/us:CYTK:filing:2026-08-28:e736aed7e0Fri, 28 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at $75.82 on 18 August 2026, $265,370https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-08-18:0898b73682Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: short interest 16,323,712 shares at the 14 August 2026 settlement, 7.69 days to coverhttps://greeksoup.ai/stocks/us/cytk/short-interest/us:CYTK:short-interest:2026-08-14:fd58b74b96Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Cytokinetics Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/cytk/filings/us:CYTK:filing:2026-08-13:1a7a0f2584Thu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Schedule 13G/A filed by Wellington Management Group LLP, 5.1% of the classhttps://greeksoup.ai/stocks/us/cytk/holders/us:CYTK:schedule-13:2026-08-13:b840fa317dThu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Blum Robert I (President & CEO) sold 7,500 shares at $76.76 on 10 August 2026, $575,700https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-08-10:bbe04dc553Mon, 10 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc. Q2 FY2026 results: revenue $29 million, net income -$199 millionhttps://greeksoup.ai/stocks/us/cytk/results/fy2026-q2/us:CYTK:result:2026-08-06:e6b647cbe8Thu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Cytokinetics Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/cytk/filings/us:CYTK:filing:2026-08-06:4850f864c5Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Cytokinetics Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/cytk/filings/us:CYTK:filing:2026-08-06:aaa968cfd8Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: short interest 15,303,504 shares at the 31 July 2026 settlement, 9.63 days to coverhttps://greeksoup.ai/stocks/us/cytk/short-interest/us:CYTK:short-interest:2026-07-31:241b5df422Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Form 144, ANDREW CALLOS plans to sell 24,000 shares worth $1.9 million around 30 July 2026https://greeksoup.ai/stocks/us/cytk/planned-sales/us:CYTK:planned-sale:2026-07-30:082134955fThu, 30 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Callos Andrew (EVP, Chief Commercial Officer) sold 14,000 shares at $79.88 on 30 July 2026, $1.1 millionhttps://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-07-30:ea50c0f192Thu, 30 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Blum Robert I (President & CEO) sold 7,500 shares at $80.87 on 27 July 2026, $606,525https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-07-27:663e642d62Mon, 27 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at $80.59 on 21 July 2026, $282,065https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-07-23:21f5360d14Thu, 23 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: short interest 17,051,981 shares at the 15 July 2026 settlement, 8.99 days to coverhttps://greeksoup.ai/stocks/us/cytk/short-interest/us:CYTK:short-interest:2026-07-15:8a887d503fWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Blum Robert I (President & CEO) sold 10 shares at $82.02 on 13 July 2026, $820https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-07-14:a16e6c16b3Tue, 14 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Cytokinetics Inc.: Blum Robert I (President & CEO) sold 7,490 shares at $82.02 on 13 July 2026, $614,330https://greeksoup.ai/stocks/us/cytk/insiders/us:CYTK:insider:2026-07-14:6d1241ae95Tue, 14 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]>